InvestorsHub Logo
Followers 232
Posts 28628
Boards Moderated 1
Alias Born 05/30/2012

Re: name post# 167564

Tuesday, 05/25/2021 1:23:05 PM

Tuesday, May 25, 2021 1:23:05 PM

Post# of 232504
And I agree with you. Many others will too when the Brazilian data comes in from a real trial not skewed in favor of flacido placebo. I would expect BP is freaking out about now as those get under way. FDA and BP have always played dirty pool. It's the only way they can maintain control. I'll stick with Nader as CEO with his many years in the hot seat and experience with the FDA. Let's blame the Advisory Board too while we are at it. This has been a team effort. He is not the Lone Ranger as some want us to believe. Many other companies have had this same kind of FDA snubbing and delays. Sure BP is active in stifling competition, that is business as usual. All surely agree that a level playing field is a worthy goal I assume. How refreshing a medical professional peer review panel would be that quarterly gets to hear Falsi and Woodcock explain their actions.

Philippine hospital information shouldn't be far off. How many more "Eraps" will we hear about, how many do we have to hear about before they give us EUA?

Just think if a Peter Thiel wanted to do something with monoclonal antibodies. Wow, surely he would want to do business with CytoDyn.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News